#ViridianTherapeutics
Sent six applications out last week. Two for @anduriltech.bsky.social, two for @danafarber.bsky.social, one for #viridiantherapeutics and one for #cvs. I’m only aiming high! Fingers crossed good things happen!

#linkedinthings #jobsearch
August 9, 2026 at 5:08 PM
Viridian Therapeutics: Jefferies Reiterates Rating: Jefferies reiterated Viridian's rating on Mar 30, 2026 (Investing.com). The note follows late-March trial data and leaves valuation upside contingent on next-stage… 👈 Read full analysis #ViridianTherapeutics #Jefferies #Investing #Biotech #Pharma
Viridian Therapeutics: Jefferies Reiterates Rating
Jefferies reiterated Viridian's rating on Mar 30, 2026 (Investing.com). The note follows late-March trial data and leaves valuation upside contingent on next-stage confirmatory results.
dlvr.it
March 30, 2026 at 1:54 PM
Viridian Wins FDA Approval for Lumvoa, Setting July Launch for TED Treatment Viridian Therapeutics said the FDA approved Lumvoa for thyroid eye...

https://www.narrowit.com/news/viridian-lumvoa-fda-approval-ted-launch-2026-06-27
#ViridianTherapeutics #FdaApproval #Lumvoa #ThyroidEyeDisease
Viridian Wins FDA Approval for Lumvoa in Thyroid Eye Disease | Narrowit.com
Viridian Therapeutics received FDA approval for Lumvoa in thyroid eye disease and plans a July U.S. launch, making the therapy the company's first commercial product.
www.narrowit.com
June 27, 2026 at 4:23 PM